glp-1 obesity drugs news today 2025 As continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: “Ozempic feet.” Story🔗below Study finds 40% of GLP-1
Description
Strong demand for metabolic disorder therapies is expected to continue driving market progression over the forecast period
Having a physical reference at your injection station eliminates the need to pull up digital resources while holding a syringe
[50] Research [edit] In September 2024, it was reported that a study found that liraglutide helped children aged 6 to 12 years of age reduce their body mass index by 7.4% in a 56-week trial
It has the same proposed mechanism: turning fiber into butyrate to support natural GLP-1 production
